View Author
dai: 068835442
scopus: 34569620700

Foekens, J.A.

(John Foekens)

Supervisor (promotor) of 3 dissertations


cancer breast patient tumor breast cancer expression level protein receptor study analysis tissue therapy tamoxifen sample factor treatment prognostic survival response status breast cancer patients table disease marker methylation value result mutation assay association adjuvant model plasminogen group tumor cells carcinoma inhibitor activator prognosis chemotherapy androgen outcome number lymph fibrotic focus method biomarker growth research detection blood month multivariate resistance tumour metastasi urokinase-type plasminogen activator fication 0.00 breast cancer res tamoxifen therapy wild-type pathway metastatic twist breast tumors prognostic value signature signi system figure tamoxifen treatment -01 cluster multivariate analysis cell lines hormone estrogen prostate




10 Most Recent Publications

KRAS and BRAF mutation status in circulating colorectal tumor cells and their correlation with primary and metastatic tumor tissue (Article)
Mostert, B. Jiang, Y. Spoel, P. van der Ramírez-Moreno, R. Verhoef, C. IJzermans, J.N.M. Gratama, J-W. Foekens, J.A. Sleijfer, S. Martens, J.W.M. Sieuwerts, A.M. Wang, H. Bolt-de Vries, J. Biermann, K. Kraan, J. Lalmahomed, Z.S. Galen, A. van Weerd, V. de
2013-07-01
KLF6-SV1 Drives Breast Cancer Metastasis and Is Associated with Poor Survival (Article)
Hatami, R. Sieuwerts, A.M. Germain, D.P. Burstein, D. Kirschenbaum, A. DiFeo, A. Foekens, J.A. Narla, G. Izadmehr, S. Yao, Z. Qiao, R.F. Papa, L. Look, M.P. Smid, M. Ohlssen, J. Levine, A.C.
2013-01-23
High TWIST1 mRNA expression is associated with poor prognosis in lymph node-negative and estrogen receptor-positive human breast cancer and is co-expressed with stromal as well as ECM related genes (Article)
Riaz, M. Sieuwerts, A.M. Look, M.P. Timmermans, A.M. Smid, M. Foekens, J.A. Martens, J.W.M.
2012-09-11
The CYP2C19*2 genotype predicts tamoxifen treatment outcome in advanced breast cancer patients (Article)
Schaik, R.H.N. van Kok, M. Span, P.N. Laarhoven, H.W.M. van Sleijfer, S. Foekens, J.A. Linn, S.C. Berns, E.M.J. Sweep, F.C.J. Vliet, M. van Fessem, M.A. van Meijer van Gelder, M.E. Seynaeve, C.M. Lindemans, J. Wesseling, J. Veer, L.J. van 't
2011-08-01
Correlation of breast cancer susceptibility loci with patient characteristics, metastasis-free survival, and mRNA expression of the nearest genes (Article)
Riaz, M. Berns, P.M.J.J. Foekens, J.A. Martens, J.W.M. Sieuwerts, A.M. Ruigrok-Ritstier, K. Weerd, V. de Groenewoud, A. Uitterlinden, A.G. Look, M.P. Klijn, J.G.M. Sleijfer, S.
2011-07-12
mRNA and microRNA expression profiles in circulating tumor cells and primary tumors of metastatic breast cancer patients (Article)
Sieuwerts, A.M. Mostert, B. Kraan, J. Spoel, P. van der Ramírez-Moreno, R. Deurzen, C.H.M. van Smid, M. Yu, J.X. Jiang, J. Wang, Y. Gratama, J-W. Sleijfer, S. Bolt-de Vries, J. Foekens, J.A. Martens, J.W.M. Peeters, D. Jongh, F.E. de Stouthard, J.M.L. Dirix, L. Dam, P.A. van Galen, A. van Weerd, V. de
2011-06-01
Gene expression profiling assigns CHEK2 1100delC breast cancers to the luminal intrinsic subtypes (Article)
Nagel, J.H.A. Peeters, J. Klijn, J.G.M. Spek, P.J. van der Foekens, J.A. Martens, J.W.M. Schutte, M. Meijers-Heijboer, H. Smid, M. Sieuwerts, A.M. Wasielewski, M. Weerd, V. de Trapman-Jansen, A.M.A.C. Ouweland, A.M.W. van den Brüggenwirth, H.T. IJcken, W.F.J. van
2011-05-26
External quality assurance of circulating tumor cell enumeration using the CellSearch® system: A feasibility study (Article)
Kraan, J. Sleijfer, S. Tibbe, A.G.J. Maestro, M. Gisbert-Criado, R. Denton, G. Bono, J.S. de Dive, C. Foekens, J.A. Gratama, J-W. Strijbos, M.H. Ignatiadis, M. Peeters, D. Pierga, J.Y. Farace, F. Riethdorf, S. Fehm, T. Zorzino, L.
2011-03-01
Clinical significance of the nuclear receptor co-regulator DC-SCRIPT in breast cancer: An independent retrospective validation study (Article)
Sieuwerts, A.M. Ansems, M. Look, M.P. Span, P.N. Weerd, V. de Galen, A. van Foekens, J.A. Adema, G.J. Martens, J.W.M.
2010-12-01
Clinical utility of level-of-evidence-1 disease forecast cancer biomarkers uPA and its inhibitor PAI-1 (Article)
Schmitt, M. Mengele, K. Napieralski, R. Magdolen, V. Reuning, U. Gkazepis, A. Sweep, F.C. Brünner, N. Foekens, J.A. Harbeck, N.
2010-11-01
  • rss icon RSS Publication Feed
  • foaf icon FOAF Profile